Opening soon—Ages 18 Years to 99 Years

Clinical Applicability of Liquid Biopsy in Chondrosarcoma

Sponsor: Medical University of Graz · NCT07492823 on ClinicalTrials.gov ↗

Bring this to your care team →

Conditions studied

Chondrosarcoma of the Bone

What it tests

laboratory biomarker analysisdiagnostic_test
Molecular pathologyother

Where it's running1 site

1 international site

Department of Orthopaedics and Trauma
Graz, Styria, Austria 8036
- Maria Anna Smolle, MD(contact)0043 316 385 81881 [email protected]

See the official eligibility language

Shown exactly as written on ClinicalTrials.gov. Your oncologist is the right person to judge whether it fits your situation.

Inclusion Criteria:

* Semimalignant or malignant cartilaginous tumour (atypical cartilaginous tumour, chondrosarcoma G1/2/3, dedifferentiated chondrosarcoma)
* Definite surgery of primary tumour

Exclusion Criteria:

* Prior tumour-specific treatment (except for biopsy)

Updated 2026-03-25 on ClinicalTrials.gov. Always confirm current details with the study team or your oncologist.